SLC1A5 and neoplasm: Knockdown of the glutamine transporter ASCT2/SLC1A5 can dramatically reduce proliferation in vitro and tumour growth in xenograft models of TNBC (Jeon et al, 2015; Van Geldermalsen et al, 2016).